ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Beacon Therapeutics (USA), INC.

Official 2024 U.S. DOL Form 5500 summary for Beacon Therapeutics (USA), INC. (Beacon Therapeutics (USA), INC. 401(k) Plan · EIN 59-3553710 · PN 001): $6.67M net assets, 56 active participants, and $2.74 per $10,000 (2.74 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorBeacon Therapeutics (USA), INC.
Filing IdentifierBeacon Therapeutics (USA), INC. 401(k) Plan · EIN 59-3553710 · PN 001
Plan Category & State401(k) Defined Contribution (FL)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$6.67M
Active Participants56
Direct Admin Fee Rate$2.74 per $10,000 (2.74 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderInsperity Retirement Services
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI